You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 19, October 25, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Use of Sublingual Nifedipine

A Continuing Concern

Arch Intern Med. 1999;159:2259-2260.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN 1995, the Cardiorenal Advisory Committee of the Food and Drug Administration, after a lengthy deliberation, unanimously decided that sublingual nifedipine should not officially be approved for the treatment of hypertensive emergencies. Despite this decision and despite authoritative voices1-4 warning against this practice, the use of short-acting nifedipine for what was perceived as hypertensive emergencies remained widespread in the United States and all over the globe.

Until recently, this intervention was used routinely in emergency departments, in nursing homes, and on hospital wards, where it often was given as a standing order, particularly in postoperative patients. In 1996, we and our colleagues5 published a review article on the putative dangers of sublingual nifedipine in hypertensive emergencies. Interestingly, short-acting nifedipine has never been approved for the treatment of any form of hypertension, emergent or not, and the safety and efficacy of this intervention remain to be determined. In view of the . . . [Full Text of this Article]

Franz H. Messerli, MD
Department of Internal Medicine
Section on Hypertensive Diseases
Ochsner Clinic
1514 Jefferson Hwy
New Orleans, LA 70121

Ehud Grossman, MD
Tel-Hashomer, Israel



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improved Quality of Stroke Care for Hospitalized Medicare Beneficiaries in Michigan
Jacobs et al.
Stroke 2005;36:1227-1231.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.